These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 11581211

  • 1. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
    Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T.
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
    [Abstract] [Full Text] [Related]

  • 2. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
    Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T.
    Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157
    [Abstract] [Full Text] [Related]

  • 3. Scanning laser system for photodynamic therapy of choroidal neovascularization.
    Obana A, Gohto Y.
    Lasers Surg Med; 2002 May; 30(5):370-5. PubMed ID: 12116330
    [Abstract] [Full Text] [Related]

  • 4. [Effect of photodynamic therapy with ATX-S 10 (Na) on experimental choroidal neovascularization].
    Hirose T, Nakajima M, Kyou T, Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2006 Jun; 110(6):445-53. PubMed ID: 16808159
    [Abstract] [Full Text] [Related]

  • 5. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
    Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T.
    Lasers Surg Med; 1999 Jun; 24(3):209-22. PubMed ID: 10229152
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.
    Retina; 2001 Jun; 21(5):499-508. PubMed ID: 11642380
    [Abstract] [Full Text] [Related]

  • 7. Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.
    Kanai M, Obana A, Gohto Y, Nagata S, Miki T, Kaneda K, Nakajima S.
    Lasers Surg Med; 2000 Jun; 26(1):48-57. PubMed ID: 10637003
    [Abstract] [Full Text] [Related]

  • 8. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.
    Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
    [Abstract] [Full Text] [Related]

  • 9. Threshold power levels for NPe6 photodynamic therapy.
    Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA.
    Ophthalmic Surg Lasers; 2000 Jul; 31(2):136-42. PubMed ID: 10743925
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization.
    Gohto Y, Obana A, Kaneda K, Miki T.
    Exp Eye Res; 1998 Sep; 67(3):313-22. PubMed ID: 9778412
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.
    Framme C, Sachs HG, Flucke B, Theisen-Kunde D, Birngruber R.
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134
    [Abstract] [Full Text] [Related]

  • 12. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [Abstract] [Full Text] [Related]

  • 13. Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization.
    Criswell MH, Ciulla TA, Lowseth LA, Small W, Danis RP, Carson DL.
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2168-74. PubMed ID: 15914638
    [Abstract] [Full Text] [Related]

  • 14. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).
    Gohto Y, Obana A, Kanai M, Nagata S, Miki T, Nakajima S.
    Ophthalmic Surg Lasers; 2000 Jun; 31(1):55-60. PubMed ID: 10976562
    [Abstract] [Full Text] [Related]

  • 15. Activation of two caspase cascades, caspase 8/3/6 and caspase 9/3/6, during photodynamic therapy using a novel photosensitizer, ATX-S10(Na), in normal human keratinocytes.
    Takahashi H, Itoh Y, Miyauchi Y, Nakajima S, Sakata I, Ishida-Yamamoto A, Iizuka H.
    Arch Dermatol Res; 2003 Nov; 295(6):242-8. PubMed ID: 13680269
    [Abstract] [Full Text] [Related]

  • 16. Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization.
    Hikichi T, Mori F, Nakajima S, Takamiya TA, Takeda M, Sasaki M, Horikawa Y, Yoshida A.
    Retina; 2001 Nov; 21(2):126-31. PubMed ID: 11321138
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad.
    Framme C, Sachs HG, Kobuch K, Flucke B, Birngruber R.
    Ophthalmologica; 2008 Nov; 222(4):254-64. PubMed ID: 18525218
    [Abstract] [Full Text] [Related]

  • 18. Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer, ATX-S10(Na).
    Nagata S, Obana A, Gohto Y, Nakajima S.
    Lasers Surg Med; 2003 Nov; 33(1):64-70. PubMed ID: 12866123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
    Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I.
    Ophthalmic Surg Lasers; 2000 Nov; 31(4):323-7. PubMed ID: 10928670
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.